CFO/Finance Head with 30 year international career in biotech & pharma. Leads, builds and transforms the full range of finance and associated operations. In 2017, completed masters level diploma at Oxford Saïd Business School, complementing extensive operational experience. At Gyroscope, completed private financing rounds during 2020-2021, and led the corporate diligence and transaction closing activities enabling the $1.5bn acquisition by in 2022. Founding management team member of start-up clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions, Aiolos Bio, launched with a Series A raise of $245m in 2023, and led the transaction closing activities enabling its $1.4bn acquisition by GSK in 2024.